EXHIBIT 107
Calculation of Filing Fee Tables
Form S-8
(Form Type)
Pfizer Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
Security Type | Security Class Title | Fee Calculation Rule | Amount Registered(1) | Proposed Maximum Offering Price Per Unit(2) | Maximum Aggregate Offering Price | Fee Rate | Amount of Registration Fee(3) | |||||||||||||||||||||||||||||||||||||
Equity | Common Stock, $0.05 par value per share | 457(h) | 320,000,000 | $27.72 | $8,870,400,000 | 0.00014760 | $1,309,271.04 | |||||||||||||||||||||||||||||||||||||
Total Offering Amounts | $8,870,400,000 | $1,309,271.04 | ||||||||||||||||||||||||||||||||||||||||||
Total Fee Offsets | — | |||||||||||||||||||||||||||||||||||||||||||
Net Fee Due | $1,309,271.04 | |||||||||||||||||||||||||||||||||||||||||||
(1) | Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement shall also cover shares of common stock, par value $0.05 per share (the “Common Stock”), of Pfizer Inc. (the “Registrant”) that may become issuable under the Amended and Restated Pfizer Inc. 2019 Stock Plan by reason of certain corporate transactions or events, including any stock dividend, stock split, recapitalization or any other similar transaction effected without the receipt of consideration which results in an increase in the number of the Registrant’s outstanding shares of Common Stock. |
(2) | Estimated solely for the purpose of calculating the registration fee pursuant to Rules 457(h) and (c) under the Securities Act. The maximum offering price per share is based on the average of the high and low prices of the Common Stock as reported on the NYSE on May 3, 2024. |
(3) | The Registrant does not have any fee offsets. |